Call and Admission (40 series)

 

Admission 2024 

CALL FOR ADMISSION TO PHD COURSES FOR THE XL CYCLE
Pharmacological Sciences PhD Course 40° series 2024/25 
Technical guidelines for the submission of the application form for PhD Courses, 40th series

Deadline May 13th, 2024 - 1 pm (CEST)

40° series PhD Projects

 

Results of the evaluation of the qualifications
to access the results, the candidate has to insert the password received when he submitted the application

 

Oral examination List
to access the list, the candidate has to insert the password received when he submitted the application

Results of oral examination


----------------------------------------------------

Within 07 JUNE 2024 the evaluating Commission will publish the results of the evaluation of the qualifications in this same website.

Everyone is asked to be present via zoom (link in above "Oral examination list" file) on Monday 10th of June at 8.45 am (CEST) to define the calendar of oral interview:

- The exam will continue: 11/06/2024  at 09:00 a.m. (CEST) - Applicants who requested it in the application form will take the oral exam via remote interview using the ZOOM videoconference tool.

1st November 2024: starting date of the PhD-Programme in Pharmacological Sciences (40th series)

The Rector approves the selection proceedings and declares the ranking official for the admission of candidates. The rankings will be made public from July 2nd 2024 through: Publication on the University’s official register and Publication on the University of Padova website: 
https://www.unipd.it/dottorato/dottorati-40-ciclo

Successful candidates must enrol by July 25th 2024.
Information on enrolment procedures will be published at the same time as the rankings. Publication of enrolment deadlines are to be considered as official notification for all intents and purposes. No personal communication will be sent to the candidates. 
Candidates granted admission to the Courses are responsible for checking enrolment dates and procedures.


----------------------------------------------------